Strangely enough I agree with some of your points as they are factual. If all of the listed/unlisted options are converted and the merger goes through then we are looking at 3.5 billion shares on issue, so if the share price hit $1 it would mean this company would be valued at $3.5 billion dollars. They are nowhere near this now, and I believe fair value for what they have reported to date sits somewhere between 8-12c.
In the webinar yesterday Adrian mentioned they now are sitting on enough cash to last a couple of years, so hopefully that removes any additional dilutive capital raises. He also mentioned they are looking to get funds onboard to soak up the supply of existing shares. So hopefully 3.5b SOI is where we are going to sit for some time as trying to constantly re-evaluate market cap is a massive pain.
They have great complementary products that when combined give them a large competitive advantage over other players in the industry, quite simply nobody is doing what they are. And it's a large market. Revenue was already growing strongly before payments, so as someone else quite rightly called out we need to wait and see what revenue looks like afterwards. If it's as many expect then I don't think CRO becoming a $3.5b company in future is a stretch, but we aren't there yet.
Patience is a virtue.
CRO Price at posting:
8.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)